These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7764434)

  • 41. Recombinant staphylokinase variants with altered immunoreactivity. II: Thrombolytic properties and antibody induction.
    Collen D; Moreau H; Stockx L; Vanderschueren S
    Circulation; 1996 Jul; 94(2):207-16. PubMed ID: 8674180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of Recombinant Methioninase for Cancer Treatment.
    Hoffman RM; Tan Y; Li S; Han Q; Yagi S; Takakura T; Takimoto A; Inagaki K; Kudou D
    Methods Mol Biol; 2019; 1866():107-131. PubMed ID: 30725412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-level expression of a biologically active staphylokinase in Pichia pastoris.
    Faraji H; Ramezani M; Sadeghnia HR; Abnous K; Soltani F; Mashkani B
    Prep Biochem Biotechnol; 2017 Apr; 47(4):379-387. PubMed ID: 27813714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant.
    Kowalski M; Brown G; Bieniasz M; Oszajca K; Chabielska E; Pietras T; Szemraj Z; Makandjou-Ola E; Bartkowiak J; Szemraj J
    Acta Biochim Pol; 2009; 56(1):41-53. PubMed ID: 19018330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient expression of unfused human alpha D-interferon in Escherichia coli using overlapping termination and initiation codons (TGATG) in its signal sequence.
    Hou YT; Lin JX; Zhou JH; Cui H
    J Interferon Res; 1986 Aug; 6(4):437-43. PubMed ID: 2945870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosis.
    Collen D; Lijnen HR; Vanderschueren S
    Verh K Acad Geneeskd Belg; 1995; 57(3):183-96; discussion 196-8. PubMed ID: 7483814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
    Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
    Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-level expression and bulk crystallization of recombinant L-methionine gamma-lyase, an anticancer agent.
    Takakura T; Ito T; Yagi S; Notsu Y; Itakura T; Nakamura T; Inagaki K; Esaki N; Hoffman RM; Takimoto A
    Appl Microbiol Biotechnol; 2006 Mar; 70(2):183-92. PubMed ID: 16012835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression and purification of the trimeric aspartate transcarbamoylase from Bacillus subtilis.
    Baker DP; Aucoin JM; Williams MK; deMello LA; Kantrowitz ER
    Protein Expr Purif; 1995 Oct; 6(5):679-84. PubMed ID: 8535162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse-phase chromatography.
    Johnson C; Royal M; Moreadith R; Bedu-Addo F; Advant S; Wan M; Conn G
    Biomed Chromatogr; 2003 Jul; 17(5):335-44. PubMed ID: 12884399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization of recombinant gene expression in Escherichia coli.
    Mattanovich D; Weik R; Thim S; Kramer W; Bayer K; Katinger H
    Ann N Y Acad Sci; 1996 May; 782():182-90. PubMed ID: 8659895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arrestin: mutagenesis, expression, purification, and functional characterization.
    Gurevich VV; Benovic JL
    Methods Enzymol; 2000; 315():422-37. PubMed ID: 10736718
    [No Abstract]   [Full Text] [Related]  

  • 53. Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS).
    Armstrong PW; Burton JR; Palisaitis D; Thompson CR; Van de Werf F; Rose B; Collen D; Teo KK
    Am Heart J; 2000 May; 139(5):820-3. PubMed ID: 10783215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes.
    Laroche Y; Heymans S; Capaert S; De Cock F; Demarsin E; Collen D
    Blood; 2000 Aug; 96(4):1425-32. PubMed ID: 10942387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression and purification of recombinant human interleukin 4 in Escherichia coli].
    Qiu Y; Sun JR; Huang YB; Huang ZH; Chen LJ; Liu Y; Lin YX
    Sheng Wu Gong Cheng Xue Bao; 2006 Nov; 22(6):962-7. PubMed ID: 17168320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of action and thrombolytic potential of staphylokinase.
    Lijnen HR
    Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prokaryotic expression of catalytic subunit of adenosine cyclic monophosphate-dependent protein kinase.
    Yonemoto WM; McGlone ML; Slice LW; Taylor SS
    Methods Enzymol; 1991; 200():581-96. PubMed ID: 1956337
    [No Abstract]   [Full Text] [Related]  

  • 58. Overexpression and purification of Thermus thermophilus elongation factors G, Tu, and Ts from Escherichia coli.
    Blank J; Grillenbeck NW; Kreutzer R; Sprinzl M
    Protein Expr Purif; 1995 Oct; 6(5):637-45. PubMed ID: 8535157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purification of recombinant Gs alpha.
    Graziano MP; Freissmuth M; Gilman AG
    Methods Enzymol; 1991; 195():192-202. PubMed ID: 1903486
    [No Abstract]   [Full Text] [Related]  

  • 60. Versatile Escherichia coli expression vectors for production of truncated proteins.
    Omori K; Akatsuka H; Komatsubara S
    Plasmid; 1994 May; 31(3):297-9. PubMed ID: 8058822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.